Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than volume increases.
The publisher's Consumer Health in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
The publisher's Consumer Health in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
EXECUTIVE SUMMARY
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
2020 IMPACT
- COVID-19 impact on consumer health
- COVID-19 country impact
- Company response
- Retailing shift
- What next for consumer health?
- Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
- Table 2 Life Expectancy at Birth 2015-2020
- Table 3 Sales of Consumer Health by Category: Value 2015-2020
- Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
- Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
- Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
- Table 7 Distribution of Consumer Health by Format: % Value 2015-2020
- Table 8 Distribution of Consumer Health by Format and Category: % Value 2020
- Table 9 Forecast Sales of Consumer Health by Category: Value 2020-2025
- Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
- Summary 1 Research Sources
2020 IMPACT
- Stockpiling leads to healthy value growth
- GSK’s range of strong brands ensures the company’s ongoing leadership
- Aspirin and ibuprofen register slower demand as all categories record strong growth
- Analgesics sales normalise to pre COVID-19 levels by 2022
- Strong growth due to population growth and consistent demand throughout the year
- Rising demand for diclofenac
- Table 11 Sales of Analgesics by Category: Value 2015-2020
- Table 12 Sales of Analgesics by Category: % Value Growth 2015-2020
- Table 13 NBO Company Shares of Analgesics: % Value 2016-2020
- Table 14 LBN Brand Shares of Analgesics: % Value 2017-2020
- Table 15 Forecast Sales of Analgesics by Category: Value 2020-2025
- Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
2020 IMPACT
- Cough remedies benefit from COVID-19
- GSK inherits strong brands to become leading player
- Demand remains highly seasonal in all product areas
- Growth in value sales decline in 2021 due to stockpiling
- Value sales continue to be supported by strong preference for self-medication
- Rigid price controls stymies growth during the forecast period
- Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
- Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
- Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
- Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
- Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
2020 IMPACT
- Stockpiling as a result of COVID-19 leads to volume increase
- Altana is new leader as its heartburn brand Controloc registers significant value sales
- Sales continue to be dominated by indigestion and heartburn remedies
- Further lockdown could lead to less food poisoning and less demand for digestive remedies
- Food poisoning a common source of sales for digestive remedies
- High demand among low-income consumers supports sales of cheaper brands and generics
- Table 23 Sales of Digestive Remedies by Category: Value 2015-2020
- Table 24 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
- Table 25 NBO Company Shares of Digestive Remedies: % Value 2016-2020
- Table 26 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
- Table 27 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
- Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025
2020 IMPACT
- Degree of stockpiling in nappy (diaper) rash treatments
- Competitive product area with little between top three players
- High birth rate continues to support strong growth in nappy (diaper) rash treatments
- Dermatologicals largely unaffected by COVID-19 and growth continues as normal
- Unit price stability returns to the category, supporting higher demand
- Prevalence of dermatological conditions remains high due to low hygiene standards
- Table 29 Sales of Dermatologicals by Category: Value 2015-2020
- Table 30 Sales of Dermatologicals by Category: % Value Growth 2015-2020
- Table 31 NBO Company Shares of Dermatologicals: % Value 2016-2020
- Table 32 LBN Brand Shares of Dermatologicals: % Value 2017-2020
- Table 33 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
- Table 34 Forecast Sales of Dermatologicals by Category: Value 2020-2025
- Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025
- NRT smoking cessation aids remains a marginal category with no growth prospects
2020 IMPACT
- Increased demand for sleep aids during early phase of pandemic
- Medizen and Sigma Pharmaceutical Industries remain in the leading positions
- Complex and highly regulated registration process discourages new launches
- Dampened growth in 2021 due to stockpiling
- Growth hampered by belief that sleep aids are psychotropic
- Sales of sleep aids likely to remain low due to limited consumer awareness
- Table 36 Sales of Sleep Aids: Value 2015-2020
- Table 37 Sales of Sleep Aids: % Value Growth 2015-2020
- Table 38 NBO Company Shares of Sleep Aids: % Value 2016-2020
- Table 39 LBN Brand Shares of Sleep Aids: % Value 2017-2020
- Table 40 Forecast Sales of Sleep Aids: Value 2020-2025
- Table 41 Forecast Sales of Sleep Aids: % Value Growth 2020-2025
2020 IMPACT
- Eye car largely unaffected by COVID-19 though increased screen time leads to demand for eye strain products
- Kahira is the leading name in eye care as its brands continue to attract consumers
- Low average unit price supports overall sales of eye care
- Pollution and increasing use of digital devices expected to maintain growth
- Severe air pollution continues to support demand for eye care products
- Drops remains the dominant format in eye care
- Table 42 Sales of Eye Care by Category: Value 2015-2020
- Table 43 Sales of Eye Care by Category: % Value Growth 2015-2020
- Table 44 NBO Company Shares of Eye Care: % Value 2016-2020
- Table 45 LBN Brand Shares of Eye Care: % Value 2017-2020
- Table 46 Forecast Sales of Eye Care by Category: Value 2020-2025
- Table 47 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025
2020 IMPACT
- Less injuries as people stay at home
- Pharmaplast dominates sales in a highly consolidated product area
- Low levels of brand loyalty define the competitive environment in wound care
- Once people start going out again, wound care will return to pre-COVID-19 value growth
- Wound care continues to underperform
- The preference for traditional home-made alternatives to remain a drag on growth
- Table 48 Sales of Wound Care by Category: Value 2015-2020
- Table 49 Sales of Wound Care by Category: % Value Growth 2015-2020
- Table 50 NBO Company Shares of Wound Care: % Value 2016-2020
- Table 51 LBN Brand Shares of Wound Care: % Value 2017-2020
- Table 52 Forecast Sales of Wound Care by Category: Value 2020-2025
- Table 53 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025
2020 IMPACT
- Huge boost to vitamins due to COVID-19, as consumers look to boost their immune health
- Local companies remain the major players in vitamins
- Paediatric vitamins remains niche with considerable room for growth
- Change in consumer behaviour, once threat of COVID-19 subsides
- Multivitamins remains dominant due to the value it represents
- Doctors are not normally consulted before Egyptians purchase vitamins
- Table 54 Sales of Vitamins by Category: Value 2015-2020
- Table 55 Sales of Vitamins by Category: % Value Growth 2015-2020
- Table 56 Sales of Multivitamins by Positioning: % Value 2015-2020
- Table 57 NBO Company Shares of Vitamins: % Value 2016-2020
- Table 58 LBN Brand Shares of Vitamins: % Value 2017-2020
- Table 59 Forecast Sales of Vitamins by Category: Value 2020-2025
- Table 60 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025
2020 IMPACT
- Consumers choose vitamin over dietary supplements to boost immune system
- Local player Eva Pharma leads a highly fragmented category, ahead of GSK
- Dietary deficiencies underpin strong demand for minerals
- Post 2020, value sales will return to normal growth levels
- Wide variety of affordable products supports sales growth
- High levels of fragmentation likely to remain a feature of dietary supplements
- Table 61 Sales of Dietary Supplements by Category: Value 2015-2020
- Table 62 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
- Table 63 Sales of Dietary Supplements by Positioning: % Value 2015-2020
- Table 64 NBO Company Shares of Dietary Supplements: % Value 2016-2020
- Table 65 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
- Table 66 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
- Table 67 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025
2020 IMPACT
- COVID-19 dampens current value growth as product area considered non-essential
- Eva Pharma remains the strong leader in weight management and wellbeing
- The preference for traditional and natural weight loss remedies continues to suppress demand
- Consumers look to shed weight, post COVID-19
- Unhealthy lifestyles and high-fat diets remain common among the population
- The ban on marketing and advertising results in lack of dynamism
- Table 68 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
- Table 69 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
- Table 70 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
- Table 71 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
- Table 72 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
- Table 73 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025
2020 IMPACT
- Value growth falls as gyms are closed due to COVID-19
- Optimum Nutrition continues to lead and gains value share in 2020
- Regulatory uncertainty affects value sales
- Post 2021, value growth should return to pre COVID-19 levels
- Younger consumers drive value sales
- Local bands have opportunity to gain ground as importers face issues
- Table 74 Sales of Sports Nutrition by Category: Value 2015-2020
- Table 75 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
- Table 76 NBO Company Shares of Sports Nutrition: % Value 2016-2020
- Table 77 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
- Table 78 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
- Table 79 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025
2020 IMPACT
- Healthy value growth, though a degree of stockpiling drives sales
- Most fragmented consumer health product area
- Strict regulation and price controls continue to stifle innovation and new product development
- Degree of stockpiling in 2020 hampers growth at start of the forecast period
- Widespread consumer acceptance of herbal remedies continues to support sales
- Herbal/traditional products faces strong competition from unpackaged alternatives
- Table 80 Sales of Herbal/Traditional Products by Category: Value 2015-2020
- Table 81 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
- Table 82 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
- Table 83 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
- Table 84 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
- Table 85 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025
2020 IMPACT
- Stockpiling lead to high current value growth of nappy (diaper) rash treatments
- Local players account for significant value share in paediatric consumer health
- Lack of paediatric consumer health products continues to limit development
- Stockpiling leads to lower value sales in some product areas in 2021
- Paediatric analgesics and paediatric digestive remedies dominant
- The development of paediatric consumer health held back by strict regulation
- Table 86 Sales of Paediatric Consumer Health by Category: Value 2015-2020
- Table 87 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
- Table 88 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
- Table 89 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
- Table 90 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
- Table 91 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
- Table 92 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
Note: Product cover images may vary from those shown
